Stockwatch: Runners And Riders In The Coronavirus Stakes

Generalist Investors Among Possible Losers In The Pandemic

With so many companies developing treatments and vaccines against coronavirus, and most other affected by the pandemic, they can’t all be winners.

StockWatch_Andy-Smith_V1_1200.jpg
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

More from COVID-19

More from Scrip